G01N 2333/175
Bunyaviridae
Official title: Bunyaviridae, e.g. California encephalitis virus, Rift valley fever virus, Hantaan virus
G01N2333/175 (Bunyaviridae) appears on 15 US grants and 19 published applications in this corpus.
Search patents in G01N- Granted patents
- 15
- Published applications
- 19
- Assignees
- 17
- Inventors
- 36
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 4 |
| 2016 | 1 | 1 |
| 2017 | 2 | 1 |
| 2018 | 0 | 2 |
| 2019 | 0 | 0 |
| 2020 | 2 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 1 |
| 2023 | 2 | 5 |
| 2024 | 1 | 1 |
| 2025 | 2 | 0 |
| 2026 | 3 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Human antibodies to rift valley fever virus11 Aug 2026US 12,703,739 B2Vanderbilt University
- Human antibodies to Crimean Congo Hemorrhagic Fever Virus4 Aug 2026US 12,699,092 B2Vanderbilt University
- Human monoclonal antibodies to hantavirus and methods of use therefore27 Jan 2026US 12,534,512 B2Vanderbilt University
- Severe fever with thrombocytopenia syndrome virus9 Sep 2025US 12,409,216 B2I.D.Bio.
- Bunyavirales vaccine26 Aug 2025US 12,397,048 B2CureVac AG
- Bunyavirales vaccine2 Apr 2026US 2026/0091101 A1CureVac AG
- Human antibodies to crimean congo hemorrhagic fever virus29 Aug 2024US 2024/0288426 A1Vanderbilt University
- Bunyavirales vaccine21 Dec 2023US 2023/0405107 A1CureVac AG
- Protein receptacle, polynucleotide, vector, expression cassette, cell, method for producing the receptacle, method of identifying pathogens or diagnosing diseases, use of the receptacle and diagnostic kit16 Nov 2023US 2023/0365622 A1FundaçãO Oswaldo Cruz
- Ebiv nucleic acid composition and application thereof16 Nov 2023US 2023/0366877 A1Wuhan Institute of Virology, Chinese Academy of Sciences
Most cited
By later US patents
- Bunyavirales vaccine9US 11,602,557 B2Cure Vac SE · 2023
- Puumala virus full-length M segment-based DNA vaccines5US 8,183,358 B2The United States of America as represented by the Secretary of the Army · 2012
- Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage2US 9,730,921 B2Duke University · 2017
- Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage1US 10,668,059 B2Duke University · 2020
- Pathogenic phlebovirus isolates and compositions and methods of use1US 9,421,250 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2016